← Back to Analyst Consensus 
PMVP Buy
PMV Pharmaceuticals, Inc.
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 4, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 13, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Mar 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Aug 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| May 30, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| May 13, 2024 | Craig-Hallum | initiate | — → Buy | $6 | 54% |
| Apr 12, 2024 | Jefferies | initiate | — → Buy | $5 | 52% |
| Mar 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Dec 27, 2023 | Ladenburg Thalmann | initiate | — → Buy | $7 | 45% |
| Oct 16, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Aug 11, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $29 | 44% |
| May 17, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $35 | 44% |
| May 11, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $15 | 52% |
| Mar 20, 2023 | HC Wainwright & Co. | maintain | — → Buy | $35 | 44% |
| Mar 2, 2023 | Oppenheimer | maintain | — → Outperform | $15 | 52% |
| Nov 17, 2022 | HC Wainwright & Co. | maintain | — → Buy | $36 | 44% |
| Jun 9, 2022 | Oppenheimer | maintain | — → Outperform | $33 | 52% |
| May 24, 2022 | Goldman Sachs | maintain | — → Buy | $25 | 54% |
| Mar 2, 2022 | Oppenheimer | upgrade | Perform → Outperform | $0 | 52% |
| Sep 22, 2021 | Goldman Sachs | upgrade | Neutral → Buy | $43 | 54% |
| Aug 19, 2021 | Oppenheimer | initiate | — → Perform | $0 | 52% |
| Aug 2, 2021 | Guggenheim | initiate | — → Buy | $56 | 52% |
| Jul 29, 2021 | HC Wainwright & Co. | initiate | — → Buy | $63 | 44% |
| Oct 20, 2020 | Cowen & Co. | initiate | — → Outperform | $0 | — |
| Oct 20, 2020 | B of A Securities | initiate | — → Buy | $42 | 53% |
| Oct 20, 2020 | Goldman Sachs | initiate | — → Neutral | $34 | 54% |
Price Target Trend
Apr 22, 2026 Oct 26, 2026
EPS Estimates
0q —
+1y —
0y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days